1. Home
  2. SGC vs LUNG Comparison

SGC vs LUNG Comparison

Compare SGC & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Superior Group of Companies Inc.

SGC

Superior Group of Companies Inc.

HOLD

Current Price

$12.42

Market Cap

207.8M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.86

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGC
LUNG
Founded
1920
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.8M
97.1M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SGC
LUNG
Price
$12.42
$1.86
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$16.00
$5.38
AVG Volume (30 Days)
33.7K
395.5K
Earning Date
05-04-2026
04-29-2026
Dividend Yield
4.93%
N/A
EPS Growth
N/A
7.64
EPS
0.14
N/A
Revenue
$566,184,000.00
$90,497,000.00
Revenue This Year
$3.23
$2.48
Revenue Next Year
$3.82
$18.46
P/E Ratio
$88.50
N/A
Revenue Growth
0.09
8.01
52 Week Low
$8.30
$1.13
52 Week High
$14.59
$2.89

Technical Indicators

Market Signals
Indicator
SGC
LUNG
Relative Strength Index (RSI) 44.50 38.13
Support Level $11.74 $1.20
Resistance Level $12.35 $2.49
Average True Range (ATR) 0.38 0.15
MACD 0.00 -0.08
Stochastic Oscillator 41.39 5.81

Price Performance

Historical Comparison
SGC
LUNG

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: